Dr Byrd discusses optimizing Ibrutinib & Idela... - CLL Support

CLL Support

23,088 members39,648 posts

Dr Byrd discusses optimizing Ibrutinib & Idelalisib.

5 Replies

You need to be a member of this community to see this post.

Read more about...
5 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib

Friends, I hope my US-based readers had a happy healthy holiday weekend. This past weekend, in...

Dr Sharman's thoughts on the race for FDA Approval for Obinituzumab, Ibrutinib and Idelalisib

Following Gilead's announcement regarding Idelalisib:...

Dr. Byrd on COVID-19

Hi, Dr. John Byrd is not only a valued member of our medical advisory board and a world leader in...

Dr Peter Hillmen of Leeds, UK discusses the place for Idelalisib in CLL treatment (Patient Power Video)

In this short video taken at iwCLL Collogne Germany, Andrew Schorr interviews Dr Hillmen: "As a...

Your opportunity to support affordable access to Ibrutinib and Idelalisib for Aussies - Submissions close next Wed 7th October

Australia's November Pharmaceutical Benefits Advisory Committe (PBAC) meeting will consider listing...